Fecal microbiota transplantation and emerging applications

@article{Borody2012FecalMT,
  title={Fecal microbiota transplantation and emerging applications},
  author={Thomas J. Borody and Alexander Khoruts},
  journal={Nature Reviews Gastroenterology \&Hepatology},
  year={2012},
  volume={9},
  pages={88-96}
}
  • T. Borody, A. Khoruts
  • Published 1 February 2012
  • Medicine
  • Nature Reviews Gastroenterology &Hepatology
Fecal microbiota transplantation (FMT) has been utilized sporadically for over 50 years. In the past few years, Clostridium difficile infection (CDI) epidemics in the USA and Europe have resulted in the increased use of FMT, given its high efficacy in eradicating CDI and associated symptoms. As more patients request treatment and more clinics incorporate FMT into their treatment repertoire, reports of applications outside of CDI are emerging, paving the way for the use of FMT in several… Expand

Paper Mentions

Interventional Clinical Trial
The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body's metabolism. Evidence from animal and human studies… Expand
ConditionsBacteria, Fecal Microbiota Transplantation, Inflammatory Bowel Disease, (+2 more)
InterventionDrug, Procedure
Interventional Clinical Trial
Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative role of cyanobacteria in ALS development, and the increasing… Expand
ConditionsAmyotrophic Lateral Sclerosis
InterventionBiological
Interventional Clinical Trial
Increasing evidences showed the microbiota effects on neuropsychiatric disorders. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation… Expand
ConditionsEpilepsy
InterventionDrug
Interventional Clinical Trial
Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which… Expand
ConditionsRadiation Enteritis
InterventionProcedure
Fecal microbiota transplantation broadening its application beyond intestinal disorders.
TLDR
This review shows that it is an exciting time in the burgeoning science of FMT application in previously unexpected areas, including metabolic diseases, neuropsychiatric disorders, autoimmune diseases, allergic disorders, and tumors. Expand
Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
TLDR
Fecal microbiota transplantation is now recommended as the most effective therapy for relapsing CDI and, with further refinement, may even be used in “first-time” CDI. Expand
Fecal microbiota transplantation: facts and controversies
TLDR
FMTs are effective against recurrent CDI, a disorder caused by disruption of the normal microbiota, and should only be given in a strict experimental setting for other conditions than CDI. Expand
Fecal microbiota transplantation in gastrointestinal diseases: what practicing physicians should know.
TLDR
FMT is particularly effective and safe in curing CDI, using a colonoscope or enema to deliver 1 to 2 infusions, and the use of FMT for non-CDI indications, such as inflammatory bowel disease and irritable bowel syndrome, is likely to increase. Expand
Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond
TLDR
An overview of the current literature on FMT’s use for recurrent, non-severe, severe, and fulminant CDI and on promising future application is presented. Expand
Fecal microbiota transplantation: Safe, simple, and effective
TLDR
The aim of this review is to provide health-care professionals with a concise summary of management options for CDI, with special focus on FMT and its indications, contraindications, and implementation experiences. Expand
Fecal microbiota transplantation: past, present and future
TLDR
FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically. Expand
Therapeutic faecal microbiota transplantation: current status and future developments
TLDR
Therapeutic FMT is a dynamic field with new and emerging indications along with ongoing developments in optimal mode of administration, including frozen GiMb extract, which has been shown highly effective in treating relapsing CDI. Expand
Therapeutic potential of fecal microbiota transplantation.
TLDR
The most current and best methods for performing fecal microbiota transplantation are reviewed and clinical observations that have implicated the intestinal microbiota in various diseases are summarized. Expand
Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective
TLDR
Fecal microbiota transplantation has emerged as an astonishingly effective cure of CDI and has gained widespread acceptance as the treatment of choice for recurrent or relapsing CDI (R-CDI) as well as severe CDI. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results
TLDR
FMT through colonoscopy was simple, safe, and 92% effective in preventing further diarrhea or CDI relapse in this group of 26 patients with recurrent CDI. Expand
The role of the intestinal microbiota in the development of atopic disorders
TLDR
The microbiota hypothesis in atopic diseases is promising and deserves further attention, but to gain more insight into the role of the gut microbiota in the etiology of atopy, large‐scale prospective birth cohort studies using molecular methods to study the Gut microbiota are needed. Expand
Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea
TLDR
The striking similarity of the recipient's and donor's intestinal microbiota following after bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches resulting in restoration of both the structure and function of the microbial communities present. Expand
A microbial symbiosis factor prevents intestinal inflammatory disease
TLDR
It is reported here that the prominent human symbiont Bacteroides fragilis protects animals from experimental colitis induced by Helicobacter hepaticus and that molecules of the bacterial microbiota can mediate the critical balance between health and disease. Expand
Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy
TLDR
Colonic infusion of donor human intestinal flora can reverse UC in selected patients and anecdotal results support the concept of abnormal bowel flora or even a specific, albeit unidentified, bacterial pathogen causing UC. Expand
The gut microbiota shapes intestinal immune responses during health and disease
TLDR
Findings indicating that developmental aspects of the adaptive immune system are influenced by bacterial colonization of the gut are discussed, and the possibility that the mammalian immune system, which seems to be designed to control microorganisms, is in fact controlled by microorganisms is raised. Expand
Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol
TLDR
It is demonstrated for the first time that fecal transplantation is practical and effective for treating relapsing CDI in a young child and recommended that this strategy be reserved for complicated cases of CDI that fail conventional therapy until randomized studies can confirm the safety and effectiveness of fecal bacteriotherapy in children. Expand
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiotaExpand
Fecal bacteriotherapy for recurrent Clostridium difficile infection.
TLDR
Fecal bacteriotherapy is a low tech procedure which is easy to perform, and breaks the cycles of repeated antibiotic use, which in turn reduces the risk of antibiotic associated resistance and adds potential cost savings when compared to repeated antibiotic administration and hospitalizations. Expand
Success of self-administered home fecal transplantation for chronic Clostridium difficile infection.
  • M. Silverman, I. Davis, D. Pillai
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2010
TLDR
Fecal transplantation by low volume enema is an effective and safe option for patients with chronic relapsing CDI, refractory to other therapies and has the potential to dramatically increase the number of patients who could benefit from this therapy. Expand
...
1
2
3
4
5
...